Enfermedad por hígado graso no alcohólica

1. Ludwig J, Viggiano RT, McGill DB. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo 2:3.  Clin Proc 1980;55:342-348.

2.  Yano E, Tagawa K, Yamaoka K, Mori M. Test validity of periodic liver function tests In a population of Japanese male bank em ployees. J Clin Epidemiol 2001;54:945-951.

3.  Bellentani S, Tiribelli C, Saccoccio G, et al. Prevalence of chronic liver disease in the general population of northern Italy: the  Dyonisos study. Hepatology 1994;20:1442-1449. 

4.  Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med  2000;132:112-117.

5.  Ratziu V, Giral P, Charlotte F, et al. Liver fibrosis in overweight  patients. Gastroenterology 2000;118:1117-1123.

6.  Skelly MM, James PD, Ryder SD. Findings on liver biopsy to investigate abnormal liver function tests in the absence of diag nostic serology. J Hepatol 2001;35:195-199.

7.  Braillon A, Capron JP, Herve MA, Degott C, Quenum C. Liver in obesity. Gut 1985;26:133-139.

8.  Nomura F, Ohnishi K, Satomura Y, Ohtsuki T, Fukunaga K, Honda M, et al. Liver function in moderate obesity: study in 534 mod erately obese subjects among 4613 male company employees. Int J Obes 1986;10:349-354.

9.  Silverman JF, O'Brien KF, Long S, et al. Liver pathology in morbidly obese patients with and Without diabetes. Am J Gastroen teroll 1990;85:1345-1355.

10.  Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utiti R, Ruggiero G. Steatosis accelerates the progression of liver dam age of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001;33:1358-1364.

11.  Ong J, Yuounossi ZM, Speer C, Olano A, Gramrich T, Boparai N. Chronic hepatitis C and superimposed nonalcoholic fatty liver  disease. Liver 2001;21:266-271.

12.  George DK, Goldwurm S, MacDonald GA, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated  with increased fibrosis. Gastroenterology 1998;114:311-318.

13.  Mendler MH, Turlin B, Moirand R, et al. insulin resistance associated hepatic iron overload. Gastroenterolc~ 1999;117:1155-1163.

14.  Fargion S, Mattloll M, Fracanzani AL, at al. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at  risk for nonalcoholic steatohepatitis. Am J Gastroenterol 2001;96:2448-2455.

15.  Graif M, Yanuka M, Baraz M, et al. Quantitative estimation of attenuation in ultrasound video images: correlation with histology  in diffuse liver disease. Invest Radiol 2000;35:319-324.

16. Mendler MH, Bouillet P, LeSidaner A, Lavoine E, Labrousse F, Sautereau D, Pillegand B. Dual-energy CT in the diagnosis and quantification of fatty liver limited clirhcal value in comperison to ultrasound scan and single-energy CT, with special reference to iron overload. J Hepatol 1998;28:785-794.

17. Ricci C, Longo R, Gioulis E, et al. Noninvaslve in vlve quantitative assessment of fat content in human liver. J Hepatol 1997;27: 108-113.

18. Szczepaniak LS, Babcock EE, Schick FD, RL, Garg A, Bums T, McGarry JD, Setin DT. Measurement of intracellular triglyceride stores by H spectroscopy and validation in vivo. Am J Physiol 1999;276:E977-E989.

19. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344:495-500.

20. Sheth SG, Gordon FD, Chopar S. Nonalcoholic steatohepatitis. Ann Intern Med 997;126:137-145.

21. Falck-Ytter Y, Younassi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosls syn-dromes. Semin Liver Dis 2001;21:71-26.

22. National Center for Statistics. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-1994, vol 1, 1994 vital health statistics.

23. Clark JM, Brancati FL, Diehi AM. Nonalcoholic fatty liver disease and its correlates in the United States. In review.

24. Pratt DS, Kaplan MM. Evaluation of abnormal liver enzyme results in asymptomatic patients. N Engl J Med 2000;342:1266-1271.

25. Bacon B, Faravash M J, Janney CG, et al. Nonalcoholic steato-hepatitis: an expanded clinical entity. Gastroenterology 1994; 107:1103-1106.

26. Powell EE, Searie J, Mortimer R. Steatohepatitls associated with limb lipodystrophy. Gastroenterology 1989;97:1022-1024.

27. Giraud NS, Borotto E, Aubert A, Capron F, Chaput JC. Excess weight risk factor for alcoholic liver disease. Hepatology 1997; 25:108-111.

28. Cope K, Risby T, Diehi AM. Increased gastrointestlnal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology 2000;119:1340-1347.

29. Nair S, Cope K, Risby T, Diehi AM. Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis. Am J Gastroenterol 2001;96:1200-1204.

30. Rolla R, Vay D, Mottaran E, etal. Detection of circulating anti-bodies against malondlaldehyde-acetaldehyde adducts in pa-tients with alcohol-induced liver disease, Hepatology 2000;31: 878-884.

31. Hodgson M, Van Thiel DH, Goodman-Klein B. Obesity and hepatotoxin risk factors for fatty liver disease. Br J Industr Med 1991;48:690-695.

32. Cotrim HP, Andrade ZA, Pararia R, Portugal M, Lyra LG, Freitas LA. Nonalcoholic steatohepatitis: a toxic liver disease in industrial workers. Liver 1999;19:299-304.

33. Assy N, Kaita K, Mymin D, Levy C, Rosser B, Minuk G. Fatty infiltration of liver inhyperlipidemlc patients, Dig Dis Sci 2000; 45:1929-1934.

34. Cortez-Pinto H, Camilo ME, Baptista A, De Oliveira AG, De Moura MC. Nonalcoholic fatty liver: another feature of the metabolic syndrome? Clin Nutr 1999;18,

35. Marceau P, Iron S, Hould FS, Marceau S, Simerd S, Thung SN, Kral JG. Liver pathology and the metabolic syndrome X in severe obesity. J Ciin Endocrinol Metab 1999;84:15i3-1517.

36. Marchesini G, Brizi M, Morselli-Labate AM, at al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999;107:450-455.

37. Kim JK, FiIImore J J, Chen Y, et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Nati Acad Sci U S A 2001;98:7522-7527

38. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li Z-W, Karin M,

Comentarios